User profiles for Bruce R. Blazar

Bruce Blazar

Verified email at umn.edu
Cited by 105248

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

…, E Bornstein, O Lambotte, D Altmann, BR Blazar… - Nature medicine, 2006 - nature.com
Chronic activation of the immune system is a hallmark of progressive HIV infection and better
predicts disease outcome than plasma viral load, yet its etiology remains obscure. Here we …

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

K Sakuishi, L Apetoh, JM Sullivan, BR Blazar… - Journal of Experimental …, 2010 - rupress.org
The immune response plays an important role in staving off cancer; however, mechanisms
of immunosuppression hinder productive anti-tumor immunity. T cell dysfunction or …

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

…, C Le, TE Defor, LJ Burns, PJ Orchard, BR Blazar… - Blood, 2005 - ashpublications.org
We previously demonstrated that autologous natural killer (NK)–cell therapy after
hematopoietic cell transplantation (HCT) is safe but does not provide an antitumor effect. We …

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

…, P Rubinstein, PB McGlave, BR Blazar… - Blood, The Journal …, 2011 - ashpublications.org
Acute graft-versus-host disease (aGVHD) is associated with high risk of morbidity and mortality
and is a common complication after double umbilical cord blood (UCB) transplantation. …

The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality

PA Taylor, CJ Lees, BR Blazar - Blood, The Journal of the …, 2002 - ashpublications.org
Immune regulatory CD4 + CD25 + cells play a vital role in the induction and maintenance of
self-tolerance and the prevention of autoimmunity. Recently, CD4 + CD25 + cells have been …

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on …

…, TE DeFor, KS Baker, BR Blazar… - Blood, The Journal …, 2002 - ashpublications.org
The potential benefits of unrelated donor marrow transplantation are offset by the immunologic
complications of graft-versus-host disease (GVHD) and infection. Therefore, we used …

[HTML][HTML] Palifermin for oral mucositis after intensive therapy for hematologic cancers

…, CF LeMaistre, EC Sung, BR Blazar… - … England Journal of …, 2004 - Mass Medical Soc
Background Oral mucositis is a complication of intensive chemotherapy and radiotherapy with
no effective treatment. We tested the ability of palifermin (recombinant human keratinocyte …

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

JN Barker, DJ Weisdorf, TE DeFor, BR Blazar… - Blood, 2005 - ashpublications.org
Limited umbilical cord blood (UCB) cell dose compromises the outcome of adult UCB
transplantation. Therefore, to augment graft cell dose, we evaluated the safety of the combined …

Advances in graft-versus-host disease biology and therapy

BR Blazar, WJ Murphy, M Abedi - Nature reviews immunology, 2012 - nature.com
Allogeneic haematopoietic stem cell transplantation is used to treat a variety of disorders,
but its efficacy is limited by the occurrence of graft-versus-host disease (GVHD). The past …

Acute graft-versus-host disease—biologic process, prevention, and therapy

R Zeiser, BR Blazar - New England Journal of Medicine, 2017 - Mass Medical Soc
When T cells from a bone marrow donor begin to attack the host within 3 months after
hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease mainly …